A cohort study conducted in Europe and the United States demonstrated an association between elevated blood levels of trimethylamine N-oxide (TMAO)—a metabolite produced in the presence of the gut microbiota—and an increased risk of progression of abdominal aortic aneurysm (AAA). The findings, which may enable more precise identification of patients with rapidly expanding AAAs or those requiring surgical intervention, were published in JAMA Cardiology.
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
